Compare · ORKA vs QUIT

ORKA vs QUIT

Side-by-side comparison of Oruka Therapeutics Inc. (ORKA) and Achieve Life Sciences Inc. (QUIT): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both ORKA and QUIT operate in Biotechnology: In Vitro & In Vivo Diagnostic Substances (Health Care), so they compete in similar markets.
  • ORKA is the larger of the two at $6.73B, about 10.1x QUIT ($666.8M).
  • ORKA has been more active in the news (12 items in the past 4 weeks vs 1 for QUIT).
  • ORKA has more recent analyst coverage (11 ratings vs 0 for QUIT).
MetricORKAQUIT
Company
Oruka Therapeutics Inc.
Achieve Life Sciences Inc.
Price
-
-
Market cap
$6.73B
$666.8M
1M return
+37.72%
-
1Y return
+251.20%
-
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Exchange
NASDAQ
NASDAQ
IPO
News (4w)
12
1
Recent ratings
11
0
QUIT

Achieve Life Sciences Inc.

AchieveRx, The Quit Company (Nasdaq: ACHV; QUIT effective November 10, 2026 ; formerly doing business as Achieve Life Sciences, Inc. ) is a late-stage pharmaceutical company with a singular focus on nicotine dependence. AchieveRx's mission is to develop medicine for people who want to quit smoking or vaping. That medicine is cytisinicline, an investigational compound. Three ideas guide the Company: simplicity, science, and second chances, for good.